Key result
Trans-coronary-venous interventions offer a potential approach for treating structural and ischemic heart disease, including refractory angina, mitral regurgitation, and stem cell delivery.
The coronary venous system offers a potential alternative route for novel interventional treatments of structural and ischemic heart disease, including refractory angina, mitral regurgitation, and stem cell delivery.
No takes yet. Share an insight, caveat, or question.
May support venous access exploration in refractory cases; leaves open need for prospective trials before adoption.
Siminiak et al. (2008) conducted a review in Structural and ischemic heart disease. Trans-coronary-venous interventions was evaluated. Trans-coronary-venous interventions offer a potential approach for treating structural and ischemic heart disease, including refractory angina, mitral regurgitation, and stem cell delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: